Market Research

Europe Bladder Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Best Price Guarantee Length Publisher Published Date SKU
from $3,500 170 Pages Data Bridge Market Research April, 2023 DAABD17954738
Best Price Guarantee
Price from $3,500
Length 170 Pages
Publisher Data Bridge Market Research
Published Date April, 2023
SKU DAABD17954738

Europe Bladder Cancer Diagnostics Market - Industry Trends and Forecast to 2030


Europe bladder cancer diagnostics market is projected to register a substantial CAGR of 8.0% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation
Europe Bladder Cancer Diagnostics Market, By Test Type (Cystoscopy, Urine Lab Test, Biopsy, Imaging Test, and Others), Stages (Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Transitional Cell Bladder Cancer, Squamous Cell Bladder Cancer, and Other Cancer Types), End User (Hospital, Diagnostic Imaging Centers, Cancer Research Institutes, Independent Diagnostic Laboratories, and Associated Labs), Distribution Channel (Direct Tender and Retail Sales), Country (Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Turkey, Belgium, and the rest of Europe) Industry Trends and Forecast to 2030

Some of the major factors contributing to the growth of the Europe bladder cancer diagnostics market are:
• Rising incidence of bladder cancer globally
• Rising awareness for the early diagnosis of bladder cancer

Market Players
Some of the key market players in the Europe bladder cancer diagnostics market are listed below:

• F. Hoffmann-La Roche Ltd
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Koninklijke Philips N.V.
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• FUJIFILM Corporation
• CANON MEDICAL SYSTEMS CORPORATION
• Siemens Healthcare GmbH
• BD
• Illumina
• Neusoft Corporation
• Abbott
• General Electric Company
• Hologic
• QIAGEN
• Cepheid.
• Ambu A/S
• MinFound Medical Systems Co., Ltd.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Europe Bladder Cancer Diagnostics Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Test Type Segment Lifeline Curve
2.8 Market End User Coverage Grid
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestle Analysis
4.2 Porter's Five Forces Model
5 Europe Bladder Cancer Diagnostics Market, Industry Insight
6 Regulatory Framework
7 Market Overview
7.1 Drivers
7.1.1 Rising Incidence Of Bladder Cancer Europely
7.1.2 Rising Awareness For The Early Diagnosis Of Bladder Cancer
7.1.3 Improved Imaging Techniques And Technology
7.1.4 Innovations In Drug Delivery To Bladder Cancer Cells
7.2 Restraints
7.2.1 High Cost Associated With Diagnosis And Treatment Of Bladder Cancer
7.2.2 Side Effects Of Bladder Cancer Treatment Drugs & Therapies
7.2.3 Late Diagnosis Of Bladder Cancer Resulting In Poor Prognosis
7.3 Opportunities
7.3.1 Increase In Diagnostic Procedures For Bladder Cancer
7.3.2 Rise In Healthcare Expenditure For Cancer Diagnosis
7.3.3 Increase In The Geriatric Population
7.4 Challenges
7.4.1 Ethical Challenges Faced During Bladder Cancer Testing
7.4.2 Stringent Regulations Among Bladder Cancer Diagnostics Tests And Procedures
8 Europe Bladder Cancer Diagnostics Market, By Test Type
8.1 Overview
8.2 Cystoscopy
8.3 Urine Lab Test
8.3.1 Urine Cytology
8.3.2 Urinalysis
8.3.3 Urine Tumor Marker Test
8.3.4 Urine Culture
8.3.5 Others
8.4 Biopsy
8.5 Imaging Test
8.5.1 Magnetic Resonance Imaging (Mri) Scan
8.5.2 Computed Tomography (Ct) Scan
8.5.3 Ultrasound
8.5.4 Intravenous Pyelogram (Ivp)
8.6 Others
9 Europe Bladder Cancer Diagnostics Market, By Stages
9.1 Overview
9.2 Stage Iv
9.3 Stage Iii
9.4 Stage Ii
9.5 Stage I
10 Europe Bladder Cancer Diagnostics Market, By Cancer Type
10.1 Overview
10.2 Transitional Cell Bladder Cancer
10.3 Squamous Cell Bladder Cancer
10.4 Other Cancer Types
11 Europe Bladder Cancer Diagnostics Market, By End User
11.1 Overview
11.2 Hospital
11.3 Diagnostic Imaging Centers
11.4 Cancer Research Institutes
11.5 Independent Diagnostic Laboratories
11.6 Associated Labs
12 Europe Bladder Cancer Diagnostics Market, By Distribution Channel
12.1 Overview
12.2 Direct Tender
12.3 Retail Sales
13 Europe Bladder Cancer Diagnostics Market, By Region
13.1 Europe
13.1.1 Germany
13.1.2 France
13.1.3 U.K.
13.1.4 Italy
13.1.5 Spain
13.1.6 Russia
13.1.7 Turkey
13.1.8 Netherlands
13.1.9 Belgium
13.1.10 Switzerland
13.1.11 Rest Of Europe
14 Europe Bladder Cancer Diagnostics Market, Company Landscape
14.1 Company Share Analysis: Europe
15 Swot Analysis
16 Europe Bladder Cancer Diagnostics Market
16.1 F. Hoffmann- La Roche Ltd
16.1.1 Company Snapshot
16.1.2 Revenue Analysis
16.1.3 Company Share Analysis
16.1.4 Product Portfolio
16.1.5 Recent Developments
16.2 Merck Kgaa
16.2.1 Company Snapshot
16.2.2 Revenue Analysis
16.2.3 Company Share Analysis
16.2.4 Product Portfolio
16.2.5 Recent Development
16.3 Thermo Fisher Scientific Inc.
16.3.1 Company Snapshot
16.3.2 Revenue Analysis
16.3.3 Company Share Analysis
16.3.4 Product Portfolio
16.3.5 Recent Development
16.4 Koninlijke Philips N.V.
16.4.1 Company Snapshot
16.4.2 Revenue Analysis
16.4.3 Company Share Analysis
16.4.4 Product Portfolio
16.4.5 Recent Development
16.5 Bio-rad Laboratories, Inc.
16.5.1 Company Snapshot
16.5.2 Company Snapshot
16.5.3 Company Share Analysis
16.5.4 Product Portfolio
16.5.5 Recent Development
16.6 Abbott
16.6.1 Company Snapshot
16.6.2 Revenue Analysis
16.6.3 Product Portfolio
16.6.4 Recent Development
16.7 Agilent Technologies, Inc.
16.7.1 Company Snapshot
16.7.2 Revenue Analysis
16.7.3 Product Portfolio
16.7.4 Recent Development
16.8 Ambu A/S
16.8.1 Company Snapshot
16.8.2 Revenue Analysis
16.8.3 Product Portfolio
16.8.4 Recent Development
16.9 Bd
16.9.1 Company Snapshot
16.9.2 Revenue Analysis
16.9.3 Product Portfolio
16.9.4 Recent Development
16.10 Canon Medical Systems Corporation
16.10.1 Company Snapshot
16.10.2 Revenue Analysis
16.10.3 Product Portfolio
16.10.4 Recent Development
16.11 Cepheid
16.11.1 Company Snapshot
16.11.2 Revenue Analysis
16.11.3 Product Portfolio
16.11.4 Recent Developments
16.12 Fujifilm Corporation
16.12.1 Company Snapshot
16.12.2 Revenue Analysis
16.12.3 Product Portfolio
16.12.4 Recent Developments
16.13 General Electric Company
16.13.1 Company Snapshot
16.13.2 Revenue Analysis
16.13.3 Product Portfolio
16.13.4 Recent Developments
16.14 Hologic Inc.
16.14.1 Company Snapshot
16.14.2 Revenue Analysis
16.14.3 Product Portfolio
16.14.4 Recent Development
16.15 Illumina Inc
16.15.1 Company Snapshot
16.15.2 Revenue Analysis
16.15.3 Product Portfolio
16.15.4 Recent Developments
16.16 Minfound Medical Systems Co.,
16.16.1 Company Snapshot
16.16.2 Product Portfolio
16.16.3 Recent Developments
16.17 Neusoft Corporation
16.17.1 Company Snapshot
16.17.2 Company Snapshot
16.17.3 Product Portfolio
16.17.4 Recent Development
16.18 Qiagen
16.18.1 Company Snapshot
16.18.2 Revenue Analysis
16.18.3 Product Portfolio
16.18.4 Recent Development
16.19 Siemens Healthcare Gmbh
16.19.1 Company Snapshot
16.19.2 Revenue Analysis
16.19.3 Product Portfolio
16.19.4 Recent Development
16.20 Time Medical Holding.
16.20.1 Company Snapshot
16.20.2 Product Portfolio
16.20.3 Recent Developments
17 Questionnaire
18 Related Reports 170
List Of Tables
Table 1 Europe Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 2 Europe Cystoscopy In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 3 Europe Urine Lab Test In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 4 Europe Urine Lab Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 5 Europe Biopsy In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 6 Europe Imaging Test In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 7 Europe Imaging Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 8 Europe Others In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 9 Europe Bladder Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
Table 10 Europe Stage Iv In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 11 Europe Stage Iii In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 12 Europe Stage Ii In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 13 Europe Stage I In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 14 Europe Bladder Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 15 Europe Transitional Cell Bladder Cancer In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 16 Europe Squamous Cell Bladder Cancer In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 17 Europe Other Cancer Types In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 18 Europe Bladder Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 19 Europe Hospital In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 20 Europe Diagnostic Imaging Centers In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 21 Europe Cancer Research Institutes In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 22 Europe Independent Diagnostic Laboratories In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 23 Europe Associated Labs In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 24 Europe Bladder Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 25 Europe Direct Tender In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 26 Europe Retail Sales In Bladder Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 27 Europe Bladder Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
Table 28 Europe Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 29 Europe Urine Lab Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 30 Europe Imaging Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 31 Europe Bladder Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
Table 32 Europe Bladder Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 33 Europe Bladder Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 34 Europe Bladder Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 35 Germany Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 36 Germany Urine Lab Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 37 Germany Imaging Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 38 Germany Bladder Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
Table 39 Germany Bladder Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 40 Germany Bladder Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 41 Germany Bladder Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 42 France Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 43 France Urine Lab Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 44 France Imaging Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 45 France Bladder Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
Table 46 France Bladder Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 47 France Bladder Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 48 France Bladder Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 49 U.K. Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 50 U.K. Urine Lab Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 51 U.K. Imaging Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 52 U.K. Bladder Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
Table 53 U.K. Bladder Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 54 U.K. Bladder Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 55 U.K. Bladder Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 56 Italy Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 57 Italy Urine Lab Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 58 Italy Imaging Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 59 Italy Bladder Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
Table 60 Italy Bladder Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 61 Italy Bladder Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 62 Italy Bladder Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 63 Spain Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 64 Spain Urine Lab Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 65 Spain Imaging Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 66 Spain Bladder Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
Table 67 Spain Bladder Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 68 Spain Bladder Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 69 Spain Bladder Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 70 Russia Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 71 Russia Urine Lab Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 72 Russia Imaging Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 73 Russia Bladder Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
Table 74 Russia Bladder Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 75 Russia Bladder Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 76 Russia Bladder Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 77 Turkey Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 78 Turkey Urine Lab Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 79 Turkey Imaging Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 80 Turkey Bladder Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
Table 81 Turkey Bladder Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 82 Turkey Bladder Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 83 Turkey Bladder Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 84 Netherlands Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 85 Netherlands Urine Lab Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 86 Netherlands Imaging Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 87 Netherlands Bladder Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
Table 88 Netherlands Bladder Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 89 Netherlands Bladder Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 90 Netherlands Bladder Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 91 Belgium Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 92 Belgium Urine Lab Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 93 Belgium Imaging Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 94 Belgium Bladder Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
Table 95 Belgium Bladder Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 96 Belgium Bladder Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 97 Belgium Bladder Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 98 Switzerland Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 99 Switzerland Urine Lab Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 100 Switzerland Imaging Test In Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 101 Switzerland Bladder Cancer Diagnostics Market, By Stages, 2021-2030 (Usd Million)
Table 102 Switzerland Bladder Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 103 Switzerland Bladder Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 104 Switzerland Bladder Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 105 Rest Of Europe Bladder Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million) 117
List Of Figures
Figure 1 Europe Bladder Cancer Diagnostics Market: Segmentation
Figure 2 Europe Bladder Cancer Diagnostics Market: Data Triangulation
Figure 3 Europe Bladder Cancer Diagnostics Market: Droc Analysis
Figure 4 Europe Bladder Cancer Diagnostics Market: Europe Vs Regional Market Analysis
Figure 5 Europe Bladder Cancer Diagnostics Market: Company Research Analysis
Figure 6 Europe Bladder Cancer Diagnostics Market: Interview Demographics
Figure 7 Europe Bladder Cancer Diagnostics Market: Market End User Coverage Grid
Figure 8 Europe Bladder Cancer Diagnostics Market: Dbmr Market Position Grid
Figure 9 Europe Bladder Cancer Diagnostics Market: Vendor Share Analysis
Figure 10 Europe Bladder Cancer Diagnostics Market: Segmentation
Figure 11 Rising Incidence Of Bladder Cancer Europely Is Expected To Drive The Growth Of The Europe Bladder Cancer Diagnostics Market From 2023 To 2030
Figure 12 Cystoscopy Segment Is Expected To Account For The Largest Share Of The Europe Bladder Cancer Diagnostics Market In 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Europe Bladder Cancer Diagnostics Market
Figure 14 Europe Bladder Cancer Diagnostics Market: By Test Type, 2022
Figure 15 Europe Bladder Cancer Diagnostics Market: By Test Type, 2023-2030 (Usd Million)
Figure 16 Europe Bladder Cancer Diagnostics Market: By Test Type, Cagr (2023-2030)
Figure 17 Europe Bladder Cancer Diagnostics Market: By Test Type, Lifeline Curve
Figure 18 Europe Bladder Cancer Diagnostics Market: By Stages, 2022
Figure 19 Europe Bladder Cancer Diagnostics Market: By Stages, 2023-2030 (Usd Million)
Figure 20 Europe Bladder Cancer Diagnostics Market: By Stages, Cagr (2023-2030)
Figure 21 Europe Bladder Cancer Diagnostics Market: By Stages, Lifeline Curve
Figure 22 Europe Bladder Cancer Diagnostics Market: By Cancer Type, 2022
Figure 23 Europe Bladder Cancer Diagnostics Market: By Cancer Type, 2023-2030 (Usd Million)
Figure 24 Europe Bladder Cancer Diagnostics Market: By Cancer Type, Cagr (2023-2030)
Figure 25 Europe Bladder Cancer Diagnostics Market: By Cancer Type, Lifeline Curve
Figure 26 Europe Bladder Cancer Diagnostics Market: By End User, 2022
Figure 27 Europe Bladder Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
Figure 28 Europe Bladder Cancer Diagnostics Market: By End User, Cagr (2023-2030)
Figure 29 Europe Bladder Cancer Diagnostics Market: By End User, Lifeline Curve
Figure 30 Europe Bladder Cancer Diagnostics Market: By Distribution Channel, 2022
Figure 31 Europe Bladder Cancer Diagnostics Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 32 Europe Bladder Cancer Diagnostics Market: By Distribution Channel, Cagr (2023-2030)
Figure 33 Europe Bladder Cancer Diagnostics Market: By Distribution Channel, Lifeline Curve
Figure 34 Europe Bladder Cancer Diagnostics Market: Snapshot (2022)
Figure 35 Europe Bladder Cancer Diagnostics Market: By Country (2022)
Figure 36 Europe Bladder Cancer Diagnostics Market: By Country (2023 & 2030)
Figure 37 Europe Bladder Cancer Diagnostics Market: By Country (2022 & 2030)
Figure 38 Europe Bladder Cancer Diagnostics Market: Test Type (2023-2030)
Figure 39 Europe Bladder Cancer Diagnostics Market: Company Share 2022 (%) 117

$3,500
$4,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings